Promed Laboratories Private Limited

Promed Laboratories Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U85195MP1971PTC001100 Incorporated 24 July 1971 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.67 Cr
▲ 671% YoY
Net loss · FY 2025
₹89.52 Lakh
Net margin -53.6%
EBITDA · FY 2025
-₹64.2 Lakh
EBITDA margin -38.4%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.68 Cr
Issued & subscribed
Open charges
₹15 Lakh
Satisfied ₹17.96 Cr
Company age
55 yrs
Est. 1971
Employees · EPFO
3
Provident fund records

About Promed Laboratories Private Limited

Data last updated:

Promed Laboratories Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 July 1971 and has been in existence for over 55 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U85195MP1971PTC001100. Its GSTIN is 23AABCP0410F1ZA (Madhya Pradesh).

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.68 Cr. It is led by directors including Subhash Rijhwani and Mahesh Badlani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.67 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹89.52 Lakh (net margin -53.6%) and EBITDA of -₹64.2 Lakh (EBITDA margin -38.4%). Revenue has grown at a compounded annual rate (CAGR) of 459% over three years and 45% over five years.

The company has about 3 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹15 Lakh and satisfied charges of ₹17.96 Cr on record. Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it; 2 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U85195MP1971PTC001100
Registration Number 001100
Incorporation Date 24 July 1971
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Promed Laboratories Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    G – 3A Shreenath Nitetan, 29 Snehlata Ganj, Indore, Madhya Pradesh, India – 452003
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Promed Laboratories Private Limited, buy the company report.

Comprehensive company report
Promed Laboratories Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Promed Laboratories is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Promed Laboratories Private Limited, buy the company report.

Financials of Promed Laboratories Private Limited

FY 2025 filings available

Promed Laboratories Private Limited reported revenue of ₹1.67 Cr (up 671% YoY) for FY 2025.

Revenue · FY 2025
₹1.67 Cr ▲ 671%
Net loss · FY 2025
₹89.52 Lakh margin -53.6%
EBITDA · FY 2025
-₹64.2 Lakh margin -38.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 671%
3 years · compounded
▲ 459%
5 years · compounded
▲ 45%
EBITDA CAGR growth
1 year
▼ 315%
3 years · compounded
▼ 11%
5 years · compounded
▲ 10%

Revenue has grown at a compounded annual rate (CAGR) of 45% over five years, including 671% growth in the latest year. EBITDA fell 315% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹64.2 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹89.52 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-38.4%
Net Profit Margin-53.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Promed Laboratories Private Limited, buy the company report.

Board of directors of Promed Laboratories Private Limited

Promed Laboratories has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Subhash RijhwaniDirector02 Mar 199432 Years 7 MonthsCurrent
Mahesh BadlaniDirector02 Mar 199432 Years 7 MonthsCurrent
Pankaj BadlaniDirector01 Sep 200323 Years 1 MonthsCurrent

Auditor

Promed Laboratories Private Limited is audited by R.D. JOSHI & CO. for the financial year 2022.

Auditor firmFinancial yearFirm registration number
R.D. JOSHI & CO.FY 2022000848C

Shareholding

The shareholding of Promed Laboratories Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Promed Laboratories Private Limited, buy the company report.

Charges & borrowings

Open charges
₹15 Lakh
Satisfied charges
₹17.96 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹0.15 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Mar 2025101088171Hdfc Bank Limited₹15 LakhOpen
09 Sep 2016100058369Others₹3.75 CrSatisfied
06 Sep 200580048723Bank of Baroda₹8.3 CrSatisfied
28 Jul 200580048721Bank of Baroda₹5.91 CrSatisfied

To see the full charge records of Promed Laboratories Private Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

Promed Laboratories Private Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 5 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 5)

SupplierAmount dueDue sinceReported on
Bhasin Packwell Pvt Ltd
Bee Pharmo Labs Private Limited
Sun Packaging
Manisha Analytical Laboratories Private Limited
Pharmaceutical Machinery Mfg Works

To see the full MSME payment records of Promed Laboratories Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Promed Laboratories has 1 associated company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.

1
Associated companies

Employees & EPFO

Promed Laboratories Private Limited has a workforce of 3 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.

Employee count
3
Active EPFO establishments
1
Employee growth
-25%

GST

Promed Laboratories has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AABCP0410F1ZAMadhya PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Promed Laboratories Private Limited, buy the company report.

Recent activity

Promed Laboratories Private Limited has 4 board changes on record since 1994: 3 appointments and 1 cessation. The latest: Jairamdas Badlani ceased to be Director on 10 Feb 2022.

AGM
Promed Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Promed Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 101088171 was registered on 11 Mar 2025.
Charges
A charge registered on 09 Sep 2016 via Charge ID 100058369 with Others was fully satisfied on 13 Oct 2023.
Charges
A charge registered on 06 Sep 2005 via Charge ID 80048723 with Bank Of Baroda was fully satisfied on 27 Sep 2023.
Charges
A charge registered on 28 Jul 2005 via Charge ID 80048721 with Bank Of Baroda was fully satisfied on 27 Sep 2023.
Ceased
Jairamdas Badlani ceased to be Director.
Charges
A charge with Others amounted to Rs. 3.75 Cr with Charge ID 100058369 was registered on 09 Sep 2016.
Charges
A charge with Bank Of Baroda of Rs. 5.91 Cr registered on 28 Jul 2005 with Charge ID 80048721 was modified on 21 Jan 2010.
Charges
A charge with Bank Of Baroda of Rs. 8.30 Cr registered on 06 Sep 2005 with Charge ID 80048723 was modified on 03 Sep 2008.
Charges
A charge with Bank Of Baroda amounted to Rs. 8.30 Cr with Charge ID 80048723 was registered on 06 Sep 2005.
Charges
A charge with Bank Of Baroda amounted to Rs. 5.91 Cr with Charge ID 80048721 was registered on 28 Jul 2005.

4 earlier events are in the company report.

Frequently asked questions

Promed Laboratories is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 July 1971 (55+ years old) and is registered under CIN U85195MP1971PTC001100.

Promed Laboratories has 3 current directors:

The latest financial statements of Promed Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Promed Laboratories is 23AABCP0410F1ZA, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Promed Laboratories is U85195MP1971PTC001100. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Promed Laboratories has 6 court cases on record: 2 filed by the company and 4 filed against it. 2 are pending. Most are in the nclt.

Promed Laboratories was incorporated on 24 July 1971, making it 55+ years old. It is registered with the Registrar of Companies, Gwalior.

Jairamdas Badlani ceased to be Director on 10 Feb 2022. Pankaj Badlani was appointed as Director on 01 Sep 2003. Mahesh Badlani was appointed as Director on 02 Mar 1994. Promed Laboratories has 4 board changes on record in total.

Promed Laboratories has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 5 overdue payments to 5 micro and small suppliers. The latest return was filed on 31 May 2019.

The registered office of Promed Laboratories is at G – 3A Shreenath Nitetan, 29 Snehlata Ganj, Indore, Madhya Pradesh, India – 452003.

Promed Laboratories operates in the pharma industry, in the drug formulation and development segment.